Purchase Order SPE2DP25P0503
- Not listed
- The U.S. government awarded a firm-fixed-price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $85,899.84 contract is to provide blood packs with anticoagulant to the Defense Logistics Agency (DLA), which serves as the medical supply chain for the U.S. Department of Defense. The contract has an ultimate completion date of July 21, 2025 and was awarded on May 22, 2025. Fenwal, Inc. is a registered...
- The U.S. Defense Department's Medical Supply Chain awarded a $30,835.84 firm fixed-price purchase order to Fenwal, Inc. for blood packs with anticoagulant on May 20, 2025, with a completion deadline of July 21, 2025. The contract, which carries no set-aside designation, will be performed at Fenwal's manufacturing facility in Lake Zurich, Illinois. Fenwal, Inc. is a subsidiary of Fresenius Kabi and operates as a specialized supplier of blood collection, processing, storage, and transfusion...
- The U.S. Defense Department's Medical Supply Chain, through its Defense Logistics Agency, awarded a $1,148.65 firm fixed-price purchase order to Fenwal, Inc. for blood collection assemblies. The contract, issued on September 16, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation and represents a competitive award to the prime contractor. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich,...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract is for the supply of a blood pack with an anticoagulant, with a ceiling value of $1,101.28 and an ultimate completion date of August 4, 2025. The contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government,...
- This federal contract award, valued at $2,570.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is a firm fixed-price purchase order for the supply of specialized medical products, such as blood collection assemblies, washing solutions, and apheresis equipment, to support critical healthcare programs, including military medical supply chains, biomedical research...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order to Fenwal, Inc. for blood packs with anticoagulant, with a ceiling value of $3,462. The award, issued on July 31, 2018, with an ultimate completion date of August 6, 2018, represents a routine consumable procurement for military medical supply operations. No set-aside designation was used for this acquisition, reflecting Fenwal's established position as a qualified supplier of specialized blood products...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
- This federal contract award, SPE2DP20P0110, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $1,468.80 firm fixed-price purchase order is for the supply of blood packs with anticoagulant. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007, and has consistently secured contract awards from multiple...
- This federal contract award, with ID SPE2DP25P0215, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment located in Lake Zurich, Illinois. The $1,101.28 firm fixed-price purchase order is for the supply of blood packs with anticoagulant, a critical medical consumable that supports healthcare and biomedical research programs, including military medical supply chains. Fenwal, Inc. is a registered federal vendor that has...
- This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award carries no set-aside designation, underscoring Fenwal's competitive standing in federal procurement. Performance will occur at the company's Lake Zurich facility. This contract supports the Defense Logistics Agency's Medical Supply Chain operations, which provide essential medical consumables to Department of Defense healthcare and military medical supply initiatives. Fenwal's blood collection assemblies and related anticoagulant products are integral to military blood banking operations and transfusion services. The company maintains a longstanding federal registration dating to April 2007 and has secured multiple contract awards from defense and civilian agencies, including the National Institutes of Health Clinical Center, Defense Health Agency, and Department of Veterans Affairs, consistently delivering specialized medical products that support critical healthcare and biomedical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/18/25 |